Literature DB >> 8059607

Neonatal hypotonia and cardiomyopathy secondary to type IV glycogenosis.

T T Tang1, A D Segura, Y T Chen, L M Ricci, R A Franciosi, M L Splaingard, M S Lubinsky.   

Abstract

A neonate with deficiency of branching enzyme (glycogenosis type IV) presented symptoms of severe hypotonia pre- and postnatally, and dilated cardiomyopathy in early infancy. The classical clinical manifestation of liver cirrhosis was not present, although amylopectin-like inclusions were found in the hepatocytes. In contrast to a previous report, the neurons in the brain stem and spinal anterior horns contained PAS-positive, diastase-resistant deposits. The combined involvement of the muscles and motor neurones could account for the severity of hypotonia. The muscle biopsy, electromyogram and biochemical and enzyme assays were helpful in establishing the diagnosis.

Entities:  

Mesh:

Year:  1994        PMID: 8059607     DOI: 10.1007/bf00294181

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  19 in total

1.  Familial cirrhosis of the liver with storage of abnormal glycogen.

Authors:  D H ANDERSEN
Journal:  Lab Invest       Date:  1956 Jan-Feb       Impact factor: 5.662

2.  Definitive prenatal diagnosis for type III glycogen storage disease.

Authors:  B Z Yang; J H Ding; B I Brown; Y T Chen
Journal:  Am J Hum Genet       Date:  1990-10       Impact factor: 11.025

3.  Type IV glycogen-storage disease. Light-microscopic, electron-microscopic, and enzymatic study.

Authors:  G A Bannayan; W J Dean; R R Howell
Journal:  Am J Clin Pathol       Date:  1976-10       Impact factor: 2.493

4.  Glycogenosis. IV. A new cause of infantile hypotonia.

Authors:  H Zellweger; S Mueller; V Ionasescu; S S Schochet; W F McCormick
Journal:  J Pediatr       Date:  1972-05       Impact factor: 4.406

5.  Lack of an alpha-1,4-glucan: alpha-1,4-glucan 6-glycosyl transferase in a case of type IV glycogenosis.

Authors:  B I Brown; D H Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1966-08       Impact factor: 11.205

6.  Nervous system involvement in type IV glycogenosis.

Authors:  K R McMaster; J M Powers; G R Hennigar; H J Wohltmann; G H Farr
Journal:  Arch Pathol Lab Med       Date:  1979-03       Impact factor: 5.534

7.  Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis).

Authors:  J M Schröder; R May; Y S Shin; M Sigmund; S Nase-Hüppmeier
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  A mild juvenile variant of type IV glycogenosis.

Authors:  E Reusche; F Aksu; H H Goebel; Y S Shin; T Yokota; H Reichmann
Journal:  Brain Dev       Date:  1992-01       Impact factor: 1.961

9.  A juvenile variant of glycogenosis IV (Andersen disease).

Authors:  A S Guerra; O P van Diggelen; F Carneiro; R M Tsou; S Simoes; N T Santos
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

10.  Polysaccharide (amylopectin-like) storage myopathy histochemical ultrastructural and biochemical studies.

Authors:  J F Pellissier; T de Barsy; J Bille; G Serratrice; M Toga
Journal:  Acta Neuropathol Suppl       Date:  1981
View more
  10 in total

1.  Glycogen storage disease type IV presenting as hydrops fetalis.

Authors:  A Alegria; E Martins; M Dias; A Cunha; M L Cardoso; I Maire
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

2.  Molecular etiology of arthrogryposis in multiple families of mostly Turkish origin.

Authors:  Yavuz Bayram; Ender Karaca; Zeynep Coban Akdemir; Elif Ozdamar Yilmaz; Gulsen Akay Tayfun; Hatip Aydin; Deniz Torun; Sevcan Tug Bozdogan; Alper Gezdirici; Sedat Isikay; Mehmed M Atik; Tomasz Gambin; Tamar Harel; Ayman W El-Hattab; Wu-Lin Charng; Davut Pehlivan; Shalini N Jhangiani; Donna M Muzny; Ali Karaman; Tamer Celik; Ozge Ozalp Yuregir; Timur Yildirim; Ilhan A Bayhan; Eric Boerwinkle; Richard A Gibbs; Nursel Elcioglu; Beyhan Tuysuz; James R Lupski
Journal:  J Clin Invest       Date:  2016-01-11       Impact factor: 14.808

3.  Severe neonatal onset of glycogenosis type IV: clinical and laboratory findings leading to diagnosis in two siblings.

Authors:  B Giuffrè; R Parini; T Rizzuti; L Morandi; O P van Diggelen; C Bruno; M Giuffrè; G Corsello; F Mosca
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

4.  Clinical and laboratory findings in four patients with the non-progressive hepatic form of type IV glycogen storage disease.

Authors:  A McConkie-Rosell; C Wilson; D A Piccoli; J Boyle; T DeClue; P Kishnani; J J Shen; A Boney; B Brown; Y T Chen
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

5.  Neuromuscular forms of glycogen branching enzyme deficiency.

Authors:  C Bruno; D Cassandrini; S Assereto; H Orhan Akman; C Minetti; S Di Mauro
Journal:  Acta Myol       Date:  2007-07

6.  Multisystem involvement in a patient due to accumulation of amylopectin-like material with diminished branching enzyme activity.

Authors:  T F Eminoglu; L Tumer; I Okur; R Olgunturk; A Hasanoglu; I I Gonul; B Dalgic
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

7.  Branching enzyme deficiency: expanding the clinical spectrum.

Authors:  Carmen Paradas; Hasan O Akman; Carolina Ionete; Heather Lau; Peter N Riskind; David E Jones; Thomas W Smith; Michio Hirano; Salvatore Dimauro
Journal:  JAMA Neurol       Date:  2014-01       Impact factor: 18.302

8.  Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene.

Authors:  Y Bao; P Kishnani; J Y Wu; Y T Chen
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

9.  Case report: adult-onset manifesting heterozygous glycogen storage disease type IV with dilated cardiomyopathy and absent late gadolinium enhancement on cardiac magnetic resonance imaging.

Authors:  Shawn Lyo; Jeremy Miles; Jay Meisner; Mark Guelfguat
Journal:  Eur Heart J Case Rep       Date:  2020-05-03

10.  A novel approach to characterize phenotypic variation in GSD IV: Reconceptualizing the clinical continuum.

Authors:  Bridget T Kiely; Rebecca L Koch; Leticia Flores; Danielle Burner; Samantha Kaplan; Priya S Kishnani
Journal:  Front Genet       Date:  2022-09-13       Impact factor: 4.772

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.